SPAXIZA
Live / Allowed — Fifth extension granted (statement of use) (as of 30 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Apr 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97888688
- Mark type
- Word mark
- Filed
- 14 Apr 2023
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for the treatment and prevention of seizures and spasms
Owner
- Fidelity Biopharma Co., New Haven, CT, US
- Fidelity Biopharma Co., New Haven, CT, US
Prosecution history
- 04 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Aug 2024 — SOU EXTENSION 1 GRANTED
- 02 Aug 2024 — SOU EXTENSION 1 FILED
- 02 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Dec 2023 — PUBLISHED FOR OPPOSITION
- 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Nov 2023 — ASSIGNED TO EXAMINER
- 09 May 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Apr 2023 — NEW APPLICATION ENTERED
- 01 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2026 — SOU EXTENSION 5 GRANTED